Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Brew

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgeryJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Contemporary Clinical Trials|November 8, 2017
The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancerAlistair Grey, Rebecca Scott, Susan Charman, et al.
BJU International|January 26, 2026
The 'Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer' (CLIMATE) trial protocolTarek Al-Hammouri, Giorgio Brembilla, Mrishta Brizmohun, et al.
BJU International|July 14, 2018
Does urinary cytology have a role in haematuria investigations?Wei Shen Tan, Rachael Sarpong, Pramit Khetrapal, et al.
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
BMJ Open|April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocolAqua Asif, Arjun Nathan, Alexander Ng, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgeryJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Contemporary Clinical Trials|November 8, 2017
The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancerAlistair Grey, Rebecca Scott, Susan Charman, et al.
BJU International|January 26, 2026
The 'Comparison of diagnostic accuracy of Luminal Index and standard of care MRI for Accelerated deTEction of prostate cancer' (CLIMATE) trial protocolTarek Al-Hammouri, Giorgio Brembilla, Mrishta Brizmohun, et al.
BJU International|July 14, 2018
Does urinary cytology have a role in haematuria investigations?Wei Shen Tan, Rachael Sarpong, Pramit Khetrapal, et al.
BJU International|September 28, 2020
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trialEoin Dinneen, Aiman Haider, Jack Grierson, et al.
BMJ Open|April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocolAqua Asif, Arjun Nathan, Alexander Ng, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
Pageof 5